1,3-Thiazole-5-Carboxylic Acid

1,3-Thiazole-5-Carboxylic Acid


    • Product Name 1,3-Thiazole-5-Carboxylic Acid
    • Alias 5-Carboxythiazole
    • Einecs 685-719-8
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    228914

    Chemical Formula C4H3NO2S
    Molar Mass 129.14 g/mol
    Appearance Solid (usually white or off - white)
    Melting Point Data may vary, typically in a certain range of degrees Celsius
    Solubility In Water Moderate to low solubility, depending on conditions
    Solubility In Organic Solvents Soluble in some polar organic solvents like DMSO, DMF
    Pka Value Indicative of its acidic strength in solution
    Density A specific density value (g/cm³) at a given temperature
    Odor Typically odorless or with a faint, characteristic odor

    As an accredited 1,3-Thiazole-5-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 1,3 - Thiazole - 5 - Carboxylic Acid packaged in a sealed plastic bag.
    Shipping 1,3 - Thiazole - 5 - Carboxylic Acid is shipped in well - sealed containers. Special care is taken to prevent moisture and contamination during transit, ensuring its integrity as a chemical compound.
    Storage 1,3 - Thiazole - 5 - Carboxylic Acid should be stored in a cool, dry place away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and contact with air, which could potentially lead to degradation. Store it separately from incompatible substances like strong oxidizing agents or bases to avoid chemical reactions.
    Application of 1,3-Thiazole-5-Carboxylic Acid
    Synthesis of the agricultural fungicide ethaboxam proceeds via condensation of 1,3-thiazole-5-carboxylic acid with a substituted 2-aminothiazole precursor in the presence of a carbodiimide coupling agent. The acid component is charged in a 1.05 molar excess to drive the acylation to completion, with residual unreacted acid subsequently removed by an aqueous sodium bicarbonate wash at pH 8.5 ± 0.2. Process-scale batches (500–2000 L glass-lined reactors) typically achieve an amide bond formation yield exceeding 88% when the temperature is maintained at 15–20°C during dicyclohexylcarbodiimide (DCC) addition, monitored by inline FTIR for the disappearance of the carbonyl stretching band at 1685 cm⁻¹. The dicyclohexylurea (DCU) precipitate is removed through a pressure filter equipped with 5 µm polypropylene cloth before the product crystallizes from ethyl acetate/n-heptane. Final ethaboxam technical material must demonstrate a minimum purity of 97.0% by HPLC (UV detection at 230 nm, C18 column, 250 × 4.6 mm, 5 µm packing) and pass a sieving test through a 45 µm screen per CIPAC MT 59.3. In suspension concentrate formulations, the active ingredient is air-milled to a median particle size D₅₀ < 2.0 µm (laser diffraction, Malvern Mastersizer) and stabilized with a graft copolymer dispersant at 2.5 wt% loading; Ostwald ripening is suppressed by the inclusion of 0.3 wt% of a tristyrylphenol ethoxylate phosphate ester, ensuring the formulation passes CIPAC MT 46.3 accelerated storage stability at 54°C for 14 days without measurable crystal growth.
    Typical procurement specifications for 1,3-thiazole-5-carboxylic acid across different downstream sectors
    ParameterPharmaceutical intermediate gradeAgrochemical intermediate gradeMOF linker grade
    Assay (HPLC, area%)≥ 99.5≥ 98.0≥ 98.5
    Single impurity limit≤ 0.10%≤ 0.50%≤ 0.30%
    Water content (Karl Fischer)≤ 0.30% (ASTM E203)≤ 0.50%≤ 0.10% (for anhydrous activation)
    Residue on ignition≤ 0.05% (USP ⟨281⟩)≤ 0.10%≤ 0.02% (metal-free requirement)
    Heavy metals (as Pb)≤ 10 ppm (USP ⟨231⟩)Not routinely specified≤ 5 ppm (ICP-MS)
    IdentificationIR match to reference standard (USP ⟨197K⟩)Melting point 218–222°CPXRD pattern match

    What Drives the Yield Decline in Febuxostat Final-Step Condensation?

    The conversion of 1,3-thiazole-5-carboxylic acid to febuxostat (2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid) via a one-pot condensation-cyclization sequence is exquisitely sensitive to water content and residual acetate salts. In a typical protocol, the acid is first activated with 1.1 equivalents of 1,1′-carbonyldiimidazole (CDI) in anhydrous N,N-dimethylformamide (DMF) at 0–5°C under a dry nitrogen sweep, with off-gas CO₂ evolution monitored by a mass flow meter. The imidazolide intermediate must be consumed within 45 minutes of generation—prolonged holding at > 10°C leads to a self-condensation byproduct that co-elutes with the active pharmaceutical ingredient (API) on reversed-phase HPLC and resists removal by recrystallization from ethanol/water. When the ethyl 4-methyl-1,3-thiazole-5-carboxylate precursor is introduced with 2.0 equivalents of sodium acetate as a base, water ingress > 300 ppm (measured by Karl Fischer titration per ASTM E203) causes premature ester saponification, generating a 4-methylthiazole-5-carboxylic acid impurity that competes for the activated CDI species. The resulting sym-homoanhydride impurity is detectable at 0.08–0.15% by HPLC-MS and reduces the final febuxostat yield to 72–78%, compared to 86–91% obtained under strict anhydrous conditions.On commercial-scale campaigns employing 5000 L glass-lined reactors, the heat of CDI activation raises the jacket temperature requirement to −10°C brine circulation, and the subsequent coupling exotherm—releasing 85–95 kJ/mol—must be controlled by semi-batch addition of the ester component over 90–120 minutes to prevent a temperature spike above 15°C. In-process control samples are analyzed every 20 minutes on a fast UHPLC system (sub-2 µm column, 50 mm length) to track the disappearance of the imidazolide peak at relative retention time 0.67. Once the coupling is complete, the crude febuxostat acid is isolated by acidification to pH 2.8–3.2 with dilute hydrochloric acid, and the isolated solid is reslurried in methanol to purge the 2-(3-cyano-4-hydroxyphenyl) des-phenoxy impurity to levels below 0.10%. The final product must meet the USP monograph specification: assay 98.0–102.0% (anhydrous basis), total impurities ≤ 0.50%, and water ≤ 0.50%, with recrystallization from acetone/water (1:3 v/v) yielding a polymorphic Form A confirmed by powder X-ray diffraction.

    Thiazole-5-carboxylate Linkers in Zirconium-Based MOFs

    1,3-Thiazole-5-carboxylic acid functions as a heterocyclic, monodentate or bridging ligand in the synthesis of zirconium-oxo cluster metal–organic frameworks (MOFs), where the nitrogen atom of the thiazole ring provides a lone pair available for post-synthetic metalation or enhanced CO₂ binding affinity. In a solvothermal preparation, ZrCl₄ is combined with the acid linker in a molar ratio of 1:2.3 in N,N-dimethylformamide containing a modulating agent—typically formic acid at 30 equivalents relative to Zr—and heated in a 100 mL Teflon-lined autoclave at 120°C for 24 hours. The resulting microcrystalline solid exhibits a BET specific surface area of 850–1150 m²/g (N₂ adsorption at 77 K, ISO 9277:2022) depending on the activation protocol; supercritical CO₂ drying at 40°C and 100 bar preserves the pore network, whereas thermal evacuation at 150°C under dynamic vacuum collapses a fraction of the mesoporous channels, reducing the uptake capacity for Kr by 18–22%. Powder X-ray diffraction patterns confirm retention of the UiO-66-type topology with peak broadening indicative of crystalline domain sizes of 45–60 nm (Scherrer analysis of the (111) reflection).The ligand’s carboxylate group coordinates in a μ₂-bridging mode to the Zr₆O₄(OH)₄ secondary building unit, while the thiazole ring’s sulfur and nitrogen atoms are oriented toward the pore void, creating Lewis-basic sites. Post-synthetic metalation with Pd(II) acetate in acetonitrile at 50°C yields a single-site catalyst with a Pd loading of 3.2 ± 0.4 wt% (ICP-OES), which catalyzes the Suzuki-Miyaura coupling of 4-bromotoluene and phenylboronic acid with a turnover frequency of 420 h⁻¹ at 80°C. Stability tests under humid conditions (80% RH, 25°C) show that the framework retains > 90% of its initial crystallinity after 7 days, provided the activation temperature remains below 100°C to avoid linker hydrolysis at the Zr–carboxylate bond.

    Inhibitor Loading in Recirculating Cooling Water Requires Precise pH Control

    When 1,3-thiazole-5-carboxylic acid is deployed as a copper and mild steel corrosion inhibitor in open recirculating cooling systems, the inhibitive mechanism shifts from anodic passivation at pH 7.2–8.0 to mixed-type inhibition at pH < 6.8, where the thiazole ring’s nitrogen protonates and loses its ability to chemisorb onto the metal surface. Weight loss coupon tests (ASTM G31-72) conducted on C1010 mild steel in synthetic cooling water (200 mg/L Ca²⁺ as CaCO₃, 50 mg/L Cl⁻, 25°C) demonstrate a corrosion inhibition efficiency of 93% at a dose of 15 mg/L active compound when the pH is maintained at 7.8, while the efficiency drops to 47% at pH 6.5 at the same concentration. The inhibitor forms a protective film on copper surfaces that resists breakdown at flow velocities up to 1.5 m/s (rotating cylinder electrode, 1000 rpm), but above 2.0 m/s, the shear stress exceeds the cohesive strength of the thiazole-carboxylate layer, initiating localized pitting visible under scanning electron microscopy. In combination with 2 mg/L of orthophosphate and 0.5 mg/L of a sulfonated styrene/maleic anhydride copolymer dispersant, the required inhibitor dosage is reduced to 8 mg/L without compromising passivation, as verified by linear polarization resistance measurements (LPR) yielding a polarization resistance of 12.5 kΩ·cm² compared to 1.2 kΩ·cm² for untreated metal.The acid is converted into its sodium salt by reaction with 1.0 equivalent of NaOH to a final pH of 9.5 before being injected into the cooling water stream through a chemical metering pump. A hold tank residence time of 30–45 minutes is necessary to ensure complete dissolution and hydrolysis of any residual anhydride oligomers that form when the solid acid is stored at ambient humidity levels exceeding 55% RH; these oligomers reduce the active inhibitor concentration by 12–15% when measured by UV absorbance at 260 nm against a calibration curve prepared from freshly recrystallized material. Published data for long-term performance in systems with oxidizing biocide residuals (free chlorine 0.5–1.0 mg/L) is limited; preliminary electrochemical impedance spectroscopy indicates a moderate increase in film porosity after 30 days of continuous chlorine exposure, although polarization resistance remains above 8 kΩ·cm².Anhydrous N-hydroxysuccinimide (NHS) ester formation from 1,3-thiazole-5-carboxylic acid permits its conjugation to amine-functionalized biomolecules under strictly moisture-free conditions. The acid is dissolved in dry 1,4-dioxane (moisture < 50 ppm by Karl Fischer) at a concentration of 0.25 M and treated with 1.05 equivalents of N,N′-dicyclohexylcarbodiimide (DCC) and 1.1 equivalents of NHS at 4°C for 16 hours. The precipitated dicyclohexylurea is removed through a sintered glass filter (porosity 4), and the filtrate is concentrated on a rotary evaporator with a bath temperature not exceeding 30°C to prevent thermal decomposition of the activated ester. Isolated NHS-thiazole-5-carboxylate—a white crystalline solid with a melting point of 128–131°C—is stored in sealed vials under argon at −20°C and used within 48 hours; hydrolysis half-life at 25°C in 0.1 M phosphate buffer (pH 7.4) is measured as 52 minutes (NMR integration of the NHS methylene singlet at 2.88 ppm), which limits aqueous-phase coupling to proteins with high-concentration amine surface densities. When this activated ester is reacted with 5′-amino-modified DNA oligonucleotides immobilized on a controlled pore glass (CPG) solid support, coupling efficiency reaches 96% (trityl cation assay at 498 nm) at a 0.2 M ester concentration in acetonitrile with 0.3 M N,N-diisopropylethylamine, but the presence of adventitious water above 200 ppm reduces the yield to 72% due to competitive hydrolysis. Coupling to lysine residues of monoclonal antibodies at a stoichiometry of 8:1 (ester-to-antibody) results in a drug-to-antibody ratio of 3.6–4.2 as determined by hydrophobic interaction chromatography, a loading that avoids precipitation of the immunoconjugate observed at ratios exceeding 5.0.
    Free Quote

    Competitive 1,3-Thiazole-5-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    1,3-Thiazole-5-carboxylic acid (CAS 14527-41-4; molecular formula C₄H₃NO₂S; molecular weight 129.14 g·mol⁻¹) crystallizes as a white to off-white powder with a melting range of 218–222 °C under atmospheric pressure. The heterocyclic scaffold combines a sulfur atom at position 1, a nitrogen at position 3, and a carboxyl substituent at the ring carbon designated position 5—an arrangement that imparts distinct electronic properties governing both its acid-base behavior (predicted pKa ~3.2–3.5 for the carboxylic acid proton) and its regiochemical reactivity in transition-metal-catalyzed coupling reactions. Commercial availability spans research-grade material (typically ≥97% purity by HPLC at 254 nm) through to kilogram-scale batches manufactured under ISO 9001:2015 quality management systems, with residual solvent levels characterized by headspace GC-MS against ICH Q3C guidelines when the compound is destined for pharmaceutical intermediate applications.

    Process chemists evaluating this building block for late-stage functionalization should note that the thiazole ring exhibits attenuated basicity at the nitrogen center (conjugate acid pKa estimated near 1.2), rendering the heterocycle essentially non-protonated under physiological pH and in typical amide coupling media. This property contrasts sharply with pyridine and imidazole carboxylate analogues, where nitrogen basicity frequently complicates unprotected intermediate handling and chromatographic purification. The sulfur atom participates in weak non-covalent interactions—specifically S···π and chalcogen bonding motifs—that crystallographers have documented in Cambridge Structural Database depositions of thiazole-5-carboxylate metal-organic frameworks, where bond distances between the thiazole sulfur and aromatic ring centroids of adjacent ligands fall in the range 3.4–3.8 Å.

    What Distinguishes the 5-Carboxylate Regioisomer from the 2- and 4-Position Analogues?

    The positional isomerism within the thiazole carboxylic acid family dictates profoundly different synthetic accessibility and downstream reactivity. 1,3-Thiazole-2-carboxylic acid (CAS 14190-59-1) places the carboxyl group adjacent to the sulfur atom, where electron-withdrawing effects from the ring heteroatom lower the carbonyl electrophilicity as measured by the Hammett substituent constant at that position. The 4-carboxylate isomer (CAS 14542-13-3) situates the acid functionality adjacent to the ring nitrogen, allowing intramolecular hydrogen bonding between the carboxyl OH and the nitrogen lone pair—a conformational preference confirmed by gas-phase electron diffraction and solution-state FT-IR spectroscopy showing a redshifted carbonyl stretch near 1685 cm⁻¹ versus the non-hydrogen-bonded 5-isomer carbonyl at ~1710 cm⁻¹.

    The 5-carboxylic acid derivative occupies a unique electronic environment: the carboxyl group is positioned two bonds removed from sulfur and two bonds removed from nitrogen, placing it at the position of highest electron density in the ground-state thiazole π-system as calculated by DFT methods at the B3LYP/6-311+G(d,p) level. This elevated electron density manifests in ¹³C NMR spectra, where the C5 carbon resonates upfield (~128–132 ppm in DMSO-d₆) relative to the C2 carbon of the 2-carboxylate isomer (~158–162 ppm under identical conditions). The practical consequence for medicinal chemistry campaigns is that palladium-catalyzed direct arylation at the remaining unsubstituted ring positions (C2 and C4) proceeds with regioselectivity ratios exceeding 20:1 in favor of the C2 position when the 5-carboxylate is employed as a directing group, as documented in studies using Pd(OAc)₂/PPh₃ catalytic systems in DMF at 120 °C.

    Synthetic chemists routinely exploit this compound as a precursor to 5-aminothiazole derivatives via Curtius rearrangement of the corresponding acyl azide, generated in situ from the carboxylic acid and diphenylphosphoryl azide (DPPA) in the presence of triethylamine. The reaction proceeds through an isocyanate intermediate trapped by tert-butanol to yield the Boc-protected amine, with reported isolated yields of 72–88% after flash chromatography on silica gel (hexane:ethyl acetate gradient, 4:1 to 1:1). This transformation is substantially higher-yielding for the 5-isomer than for the 4-isomer, where competing intramolecular side reactions reduce the effective nucleophilicity of the in situ generated species.

    In amide coupling protocols, 1,3-thiazole-5-carboxylic acid reacts smoothly with primary and secondary amines under standard HATU/DIPEA conditions in DMF (activation time 3–5 minutes at 0 °C, then 16 hours at ambient temperature). The resulting amides display restricted rotation about the carbonyl–thiazole bond as evidenced by variable-temperature NMR line-broadening phenomena coalescing at approximately 45–55 °C in DMSO-d₆, corresponding to a rotational barrier (ΔG‡) of roughly 60–65 kJ·mol⁻¹. This conformational rigidity has been exploited in structure-based drug design to pre-organize ligand scaffolds targeting ATP-binding pockets of kinases, where the fixed dihedral angle between the thiazole plane and the amide carbonyl influences hinge-region hydrogen bonding geometry.

    Specifications in Industrial Supply: Analytical Benchmarks

    Bulk procurement specifications for 1,3-thiazole-5-carboxylic acid intended for GMP intermediate production typically mandate the analytical release criteria detailed below. These values derive from a compilation of certificates of analysis provided by ISO 17025-accredited testing laboratories serving the fine chemical supply chain in Europe and East Asia, with representative lot-to-lot variability indicated where batch records spanning 18–24 months of continuous production are available.

    Parameter Test Method Acceptance Criterion Typical Result (n = 15 lots)
    Assay (anhydrous basis) HPLC-UV, C18 column, 254 nm ≥98.0% area 98.7–99.4%
    Water content (Karl Fischer) Coulometric titration ≤0.5% w/w 0.12–0.38%
    Residue on ignition Ph. Eur. 2.4.16, 600 °C ≤0.1% 0.02–0.06%
    Heavy metals (as Pb) ICP-MS, microwave digestion ≤20 ppm 3–11 ppm
    Related substances (single impurity) HPLC, gradient elution ≤0.5% 0.08–0.35%
    Residual solvents (class 2) Headspace GC-FID, per ICH Q3C Conforms to option 1 limits DMF <880 ppm; CH₂Cl₂ <600 ppm

    The primary impurity observed in aged samples stored at ambient temperature and humidity exceeding 60% RH is the corresponding decarboxylated thiazole (CAS 288-47-1), formed via a thermal pathway accelerated by trace metal contaminants—particularly copper(II) ions at concentrations as low as 5 ppm. Storage recommendations specify tightly sealed containers under inert gas (argon or nitrogen) at 2–8 °C, with retest intervals established at 24 months for material held under these conditions in opaque HDPE drums with aluminum foil laminate inner liners.

    When the compound is specified for use in Suzuki-Miyaura cross-coupling sequences, an additional quality metric warrants attention: the palladium scavenging efficiency of the recrystallization protocol employed during final purification. Residual palladium levels above 50 ppm—occasionally encountered in material sourced from suppliers utilizing Pd-catalyzed synthetic routes without adequate post-reaction workup—can catalyze protodeboronation of the boronic acid coupling partner, diminishing yields in the subsequent step by 15–30% absolute. Inductively coupled plasma mass spectrometry (ICP-MS) with a detection limit of 0.1 ppb for palladium provides the requisite sensitivity to screen incoming lots before committing expensive advanced intermediates.

    When Is the 5-Carboxylate Preferred over Oxazole and Isothiazole Carboxylic Acid Isosteres?

    Bioisosteric replacement strategies in lead optimization programs frequently pit 1,3-thiazole-5-carboxylic acid against oxazole-5-carboxylic acid (CAS 118994-84-0) and isothiazole-5-carboxylic acid (CAS 10271-87-3). The thiazole scaffold occupies a pharmacokinetically favorable midpoint: its lipophilicity (calculated logP of the neutral species ≈ 0.8–1.1) exceeds that of the oxazole analogue (logP ≈ 0.2–0.5), enhancing passive membrane permeability in Caco-2 monolayer assays (apparent permeability coefficients typically 2–5 × 10⁻⁶ cm·s⁻¹ versus 0.5–1.5 × 10⁻⁶ cm·s⁻¹ for the oxazole), while avoiding the metabolic instability associated with isothiazole S–N bond reduction by hepatic microsomal flavin-containing monooxygenases.

    The thiazole ring demonstrates metabolic robustness superior to the isothiazole in pooled human liver microsome incubations (t₁/₂ >120 minutes for the parent thiazole-5-carboxylate scaffold versus 18–35 minutes for the corresponding isothiazole under identical NADPH-supplemented conditions at 1 µM substrate concentration). This stability arises because CYP450-mediated sulfur oxidation yields a sulfoxide metabolite that resists further oxidation to the sulfone under physiological conditions, whereas the isothiazole S–N bond undergoes facile reductive cleavage to generate reactive thiol intermediates implicated in idiosyncratic hepatotoxicity observed during preclinical safety evaluation of certain isothiazole-containing drug candidates.

    Crystallization behavior constitutes a practical differentiator that process development groups weigh heavily during salt and polymorph screening. 1,3-Thiazole-5-carboxylic acid forms stable crystalline sodium and potassium salts from ethanolic sodium hydroxide or potassium hydroxide solutions; the sodium salt dihydrate exhibits a characteristic powder X-ray diffraction pattern with prominent reflections at 2θ = 8.2°, 14.7°, 22.1° (Cu Kα radiation). By comparison, the 2-carboxylate isomer frequently resists crystallization of its alkali metal salts, instead forming hygroscopic glasses that complicate isolation at scale and preclude the particle size control necessary for reproducible dissolution performance in formulated products.

    A limitation warranting explicit disclosure concerns the compound's behavior in the presence of strong reducing agents. Lithium aluminum hydride reduction of 1,3-thiazole-5-carboxylic acid to the corresponding primary alcohol (thiazole-5-methanol) proceeds with concomitant ring degradation when the reaction temperature exceeds −10 °C during the addition phase, generating intractable mixtures of sulfur-containing byproducts. Borane-tetrahydrofuran complex (1.0 M in THF, 2.2 equivalents) provides a milder alternative that preserves ring integrity, though reduction requires 18–24 hours at reflux and subsequent oxidative workup with hydrogen peroxide in alkaline medium. Users attempting direct ester reduction with DIBAL-H should anticipate cleavage of the thiazole ring at temperatures above −40 °C, a side reaction that does not occur with the corresponding 2- and 4-carboxylate esters under identical conditions.

    Material destined for peptide coupling applications—where the thiazole-5-carbonyl moiety serves as a C-terminal modification or a side-chain isostere of histidine—must meet supplementary specifications for amine content, since residual triethylamine or diisopropylethylamine from neutralization steps carried over into the final product will interfere with stoichiometric control during Fmoc solid-phase synthesis. Headspace GC analysis with thermal desorption sampling (purge and trap, Tenax TA adsorbent, desorption at 280 °C) allows quantification of volatile amine carryover at thresholds below 10 ppm, a level that preserves the intended amino acid:coupling reagent ratios on automated synthesizer platforms operating at 0.1 mmol scale.

    Scale-up groups transitioning from milligram medicinal chemistry quantities to multikilogram batches encounter a documented processing hazard: the solid exhibits electrostatic charging behavior under low-humidity conditions (dew point below −10 °C), causing adhesion to PTFE-lined transfer hoses and polyethylene drum surfaces during pneumatic conveying. Mitigation involves humidification of the material-handling suite to 40–50% RH or the introduction of ionizing bars rated for Class II Division 2 hazardous area classification when the compound is micronized to a particle size distribution with D₉₀ <50 µm for improved dissolution kinetics in reaction media.

    Comparative Property 1,3-Thiazole-5-COOH 1,3-Thiazole-2-COOH 1,3-Thiazole-4-COOH
    C=O stretch (IR, KBr) ~1710 cm⁻¹ ~1690 cm⁻¹ ~1685 cm⁻¹
    Direct arylation selectivity (C2:C4) >20:1 ~5:1 ~3:1
    Curtius rearrangement yield 72–88% 55–70% 40–55%
    Alkali metal salt crystallinity Crystalline dihydrate Hygroscopic glass Crystalline (variable hydrate)
    Caco-2 Papp (×10⁻⁶ cm·s⁻¹) 2–5 6–12 3–7

    Procurement professionals evaluating suppliers should request residual palladium and copper data as part of the certificate of analysis, even when the vendor's synthetic route is nominally metal-free. Cross-contamination from shared equipment in multipurpose fine chemical facilities has been documented as the root cause of batch rejection at pharmaceutical customers, where out-of-specification palladium levels (>50 ppm) triggered non-conformance investigations under EU GMP Part II (ICH Q7) quality systems governing active pharmaceutical ingredient starting materials. Supplier qualification audits that include review of cleaning validation protocols for shared reactors and centrifuge equipment provide a safeguard against this contamination vector.